Asker Healthcare Group has signed a definitive agreement to acquire 80% of the shares in Finmed Group, marking its strategic entry into the French healthcare market. This transaction serves as a platform acquisition, providing the Swedish-based group with a robust foundation to expand its presence in one of Europe's largest medical device markets. The deal was structured to ensure management continuity, with Finmed's leadership, including Elie Fiani and Jean-Marc Soghomonian, remaining at the helm to drive the next phase of development. The rationale for the operation is highly strategic for both parties: for Asker, Finmed provides critical local expertise and access to a wide network of French hospitals and pharmacies, while for Finmed, the integration into a larger pan-European group provides the financial firepower and technical resources needed to accelerate innovation and pursue its own external growth. The partnership aims to professionalize Finmed's organizational structure and governance while leveraging Asker's centers of excellence to enhance the service offering for French clients.

Founded as a family-led organization, Finmed Group is a prominent French distributor and solution provider for the medical technology sector. The company specializes in the commercialization of medical devices, equipment, and related consumables, operating through a multi-channel model that includes direct sales, specialized resellers, and e-commerce platforms. Finmed serves a broad spectrum of healthcare stakeholders, including pharmacies, public and private hospitals, and various healthcare institutions across France. Its value proposition is centered on the democratization of medical innovation, ensuring that cutting-edge technologies are accessible to both healthcare professionals and patients. The group’s strategy emphasizes operational excellence and customer satisfaction, acting as a trusted intermediary between global medical manufacturers and the domestic healthcare market. By providing integrated services alongside its product portfolio, Finmed supports the modernization of French medical infrastructure, maintaining a strong focus on professional development and corporate social responsibility (CSR) to ensure sustainable impact in the European healthcare landscape.